1 / 18

Parkinson’s Disease

Parkinson’s Disease. JP. Overview. Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS Develops over months or several years Classification: movement disorder Combination of tremor, rigidity and akinesia. Causes.

barney
Download Presentation

Parkinson’s Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Parkinson’s Disease JP

  2. Overview • Idiopathic PD • Clinically and pathologically distinct from other parkinsonian syndromes • Degenerative disorder of the CNS • Develops over months or several years • Classification: movement disorder • Combination of tremor, rigidity and akinesia

  3. Causes • Not well known • Relatively uniform world-wide prevalence suggests that it is not environmental • Possible factors: • Nicotine • Less prevalent in smokers • Genetic factors • Not usually familial • Mutation in parkin gene may account for cases with an onset below the age of 40

  4. Epidemiology • Prevelence (per 100,000): • Sweden 22.5 • USA 20.5 • Japan 16.9 • England 12 • Italy 10 • Hair colour • Black (least) • Brown 40% more likely • Blonde 60% more likely • Red 100% more likely • Melanin (pigment) is initally made the same way as dopamine

  5. Epidemiology – cont. • Age • Very uncommon <30 • Risk sharply increases at the age of 60 • Gender • More common in males

  6. Pathophysiology • Neurons from the substantianigra (basal ganglia) extend into the putamen and caudate • Release dopamine • PD: • Breakdown in connection between the substantianigra and the putamen • Symptoms occur when 20-50% levels of normal dopamine • Usually around 60-80% of cells die in the substantianigra • Lewy Bodies when found in the substantianigra is characteristic • Dense protein core

  7. Clinical Symptoms • Initially tremor and slowness • Limbs and joints feel stiff and ache • Fine movements become difficult • Difficulty “rising from a chair” or “getting in or out of bed” • Writing becomes small (micrographia) and spidery • Relatives notice slowness and an impassive face • Nearly always more prominent on one side

  8. Clinical Signs • Tremor • Rest tremor usually decreases with action • Characteristic • Rigidity • Stiffness is equal in opposing muscle groups • ‘Lead pipe’ • Limbs, neck and axial muscles • Akinesia & Bradykinesia • Difficulty initiating movement • Rapid fine finger movements are greatly affected • Facial immobility • Reduced blink rate • Serpentine stare

  9. Clinical Signs – cont. • Postural changes • Stoop • Festinant gait (hurrying) and shuffling with poor arm swinging • Balance deteriorates • Speech • Monotone • Progresses to slurring dysarthria • Other symptoms • Heartburn, dribbling, dysphagia, constipation and weight loss • Urinary difficulties • Skin is greasy and sweating excessive

  10. Course of the disease • Worsens over 10-15 years • Death results from bronchopneumonia

  11. Differentials • Alzheimer’s disease • Multi-infarct dementia • Repeated head injury • Drug-induced • Late effects of severe hypoxia or carbon monoxide poisoning • Hypothyroidism • Depression

  12. Diagnosis • No laboratory test • Made by history and recognising physical signs

  13. Treatment • No drugs alter the course of disease • Levodopa • Effective in initial symptom treatment • Issues: • Fluctuates between effectiveness • After several years levodopa becomes inefficient • Side effects are severe: • Initially: nausea and vomitting • Later: episodes of immobility, dyskinesias • Dopamine receptor agonists • Generally less effective than levodopa but less side effects • Usually primary treatment unless levodopa is absolutely necessary • Used below the age of 70

  14. Surgery • Stereotactic neurosugery • Provides effective, temporary improvement in tremor and dyskinesia • Used before levodopa and in the past decade has become more popular

  15. Physiotherapy • Can improve gait • Modifications at home • Eg. Remove fiddly stuff from clothing • Walking aids

  16. Psychiatric Aspects • Depression is common

  17. Videos • http://www.youtube.com/watch?v=_6u2W1mzCeM&feature=related • http://www.youtube.com/watch?v=gboQaXv9CuM&feature=related • http://www.youtube.com/watch?v=pOhBtTYfSE4

More Related